Ralph Gruppo Free People Check 

( I'm Ralph Gruppo)

Loading...

Images of Ralph Gruppo

(1 - 1 from 1 )

News

(1 - 4 from 8
)

Catalyst Biosciences Announces Publication of Marzeptacog

www.globenewswire.com
4 Sept — ... of hemophilia A or B with inhibitors, particularly via subcutaneous administration,” said Ralph Gruppo, M.D., lead study author. › › Cataly...

Catalyst Biosciences Announces Publication of Marzeptacog ...

ir.catalystbiosciences.com
... for the treatment of hemophilia A or B with inhibitors, particularly via subcutaneous administration," said Ralph Gruppo , M.D., lead study author. › news-release-details

History of Changes for Study: NCT ClinicalTrials.gov

clinicaltrials.gov
Contact:Principal Investigator: Ralph Gruppo, M.D.. United States, Oregon. University of Oregon [Recruiting] Portland, Oregon, United States › history › NCT

The World's Most Common Inherited Bleeding Disorder That ...

www.statnews.com
17 Mar — ... disease,” says Ralph Gruppo, M.D., Director, Comprehensive Hemophilia and Thrombosis Center at the Cincinnati Children's Hospital. › sponsor › › wo...
Save as document
+1